awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q47548041-3BA7E079-6C78-4AE2-B3FB-28FF7D0A3049
Q47548041-3BA7E079-6C78-4AE2-B3FB-28FF7D0A3049
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47548041-3BA7E079-6C78-4AE2-B3FB-28FF7D0A3049
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.
P2860
Q47548041-3BA7E079-6C78-4AE2-B3FB-28FF7D0A3049
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47548041-3BA7E079-6C78-4AE2-B3FB-28FF7D0A3049
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11db3b1c5c3832dcd4b4803a05054c6a19b3de0a
P2860
Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies.